Inhibition of Glycogen Synthase Kinase 3 (GSK-3) synergizes with anti-PD-1 by potentiating tumor-infiltrated CD8+T-cells.

Krueger, J, Taylor, A orcid.org/0000-0003-2295-2611, Kazanova, A et al. (4 more authors) (2020) Inhibition of Glycogen Synthase Kinase 3 (GSK-3) synergizes with anti-PD-1 by potentiating tumor-infiltrated CD8+T-cells. In: Cancer Immunology Research. AACR Special Conference on Tumor Immunology and Immunotherapy, 17-20 Nov 2019, Boston, Massachusetts, USA. American Association for Cancer Research Inc. , pp. 60-61.